Governments around the world have made international commitments to reduce their environmental impact and protect nature. Policy frameworks have been established to facilitate and drive progress against agreed-upon targets. These directly impact end-to-end activities for the biopharmaceutical, pharmaceutical, and medical device sectors, including research and development, manufacturing,...
ISPE recently announced ISPE AI®, an initiative aimed at aiding the pharmaceutical industry in realizing the potential of artificial intelligence (AI). The initiative will include a multifaceted approach to...
The proliferation of digital tools available in the pharmaceutical industry, including artificial intelligence (AI) and machine learning (ML), is revolutionizing drug discovery and manufacturing processes.
In the rapidly evolving pharmaceutical landscape, artificial intelligence (AI) has been hailed as having the potential to revolutionize everything from drug discovery to pharmaceutical manufacturing. As the industry seeks to further explore and invest in potential opportunities for improvement and growth with AI, pursuing a thoughtful and informed approach to AI strategy planning becomes...
